The company notified healthcare providers after receiving 26 complaints about Cardiosave devices, used to support severely ill patients, unexpectedly shutting down.
Getinge’s heart assist pump shutdown problem given FDA Class I recall tag Read More »
En el panorama actual, donde la búsqueda de fuentes de energía limpia y sostenible se ha vuelto una prioridad global, las células de combustible emergen como una tecnología prometedora capaz de revolucionar la forma en que generamos y utilizamos la energía. Estos d …
The company also plans to submit results of a pivotal trial for a version of its device that can be worn for a year.
Senseonics seeks iCGM designation for implantable glucose monitor Read More »
The request for more information pushes back the timeline of the merger as regulators take a more active stance in healthcare M&A oversight.
DOJ hits UnitedHealth, Amedisys with second request over $3.3B deal Read More »
The value-based primary care chain posted a net loss of $270.7 million in the second quarter, nearly 19 times larger than its loss in the prior-year period.
Cano Health exploring sale, lays off 700 employees Read More »
Independent evaluation could help the healthcare industry figure out which digital health products are backed by evidence, argues Caroline Pearson, executive director of the nonprofit Peterson Center on Healthcare.
Q&A: ‘Chaotic’ digital health market needs independent evaluation, new institute says Read More »
Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.
Annexin Pharmaceuticals AB announces that an independent evaluation of potential signals of effect has been carried out in the company’s Phase 2-study in retinal vein occlusion with the investigational new drug ANXV.
Promising signals of effect in Annexin’s RVO-study Read More »
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Phase III bridging clinical trial of Hexvix® for bladder cancer diagnosis met the primary endpoint.
La esperanza de vida es un tema de gran interés en el ámbito científico y social, y una tendencia notable es que las mujeres suelen vivir más que los hombres. A lo largo de la historia, se ha observado esta diferencia en la esperanza de vida entre los géneros, gene …
